English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA pesar de las directrices, el tratamiento de primera línea para el estado epiléptico a menudo es inadecuado. Los estudios sugieren que hasta dos tercios de los pacientes reciben dosis subclínicas de benzodiazepinas, ya sea antes de llegar a un hospital o durante el tratamiento hospitalario de emergencia. ¿Hay soluciones?
Tag: Status Epilepticus
Traitement de première intention inapproprié de l’état de mal épileptique : problématique et solutions
Malgré les recommandations, le traitement de première intention de l’état de mal épileptique est souvent inapproprié. Des études suggèrent que jusqu’à deux tiers des patients reçoivent des doses subcliniques de benzodiazépines, soit avant d’arriver à l’hôpital, soit pendant un traitement hospitalier d’urgence. Existe-t-il des solutions ?
International recommendations for diagnosis and treatment of new-onset refractory status epilepticus (NORSE)
First-line immunotherapy and the ketogenic diet are two main recommendations for treatment of NORSE of unknown cause, according to results from an international consensus group. Dr. Maryam Nabavi Nouri interviews first author Dr. Ronny Wickstrom.
Inadequate first-line treatment for status epilepticus: The issue and solutions
A benzodiazepine is the first-line treatment of choice for status epilepticus. Despite guidelines from 2012 and 2016 thta recommend medication types, doses, and means of administration, benzodiazepines are often underdosed, or not given at all.
Addressing status epilepticus management in low-resource regions: “Where do we fit in?”
Low-resource areas face multiple challenges to diagnosing and treating long-lasting seizures, or status epilepticus. We talked with neurologists in four countries about how status epilepticus is managed in their areas.
Seizures in the Canadian Arctic: A public health crisis, hidden in plain sight
He set out to research the effect of polar day-night patterns on seizure frequency and epilepsy. He found something he never expected: a public health crisis in one of the wealthiest countries in the world, relevant to geographically isolated communities and Indigenous peoples.
Podcast – Persistent seizures: How to use the ketogenic diet for super-refractory status epilepticus
A recent paper in Neurology Clinical Practice offers practical considerations for using the ketogenic diet in patients with seizures that last more than 24 hours, a condition known as super-refractory status epilepticus. ILAE spoke with two of the authors – dietitian Neha Kaul and epileptologist Joshua Laing.
Podcast – Dieta cetogénica y estatus epiléptico súper refractario
Un artículo reciente en “Neurology Clinical Practice” ofrece consideraciones prácticas para el empleo de la dieta cetogénica en pacientes con estatus epiléptico superrefractario. La ILAE habló con dos de los autores del artículo. (Podcast en ingles; transcripcion en español.)
The ketogenic diet for super-refractory status epilepticus
The ketogenic diet is emerging as a potential treatment option for all stages of status epilepticus, a condition in which seizures persist for more than several minutes.
Food for thought: The ketogenic diet as epilepsy treatment
Treating epilepsy with diet is not a new concept, but it’s gained popularity and credibility in the past 25 years.
New-onset refractory status epilepticus (NORSE): Awareness and research
This rare but life-threatening condition is often due to an autoimmune response. Speedier diagnosis and more effective treatments are priorities.
When seizures don’t stop: What’s the latest in treating status epilepticus?
When seizures last longer than about 5 minutes–a condition called status epilepticus–emergency treatment is required. About two-thirds of people respond to initial treatment with benzodiazepines, but the others need a second drug. Which drug to choose is a matter of some debate.